Regeneron Pharmaceuticals shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Regeneron Pharmaceuticals by Ensign Peak Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $45M | 43k | 1051.24 |
2024-06-30 | $135M | 129k | 1051.03 |
2024-03-31 | $128M | 133k | 962.49 |
2023-09-30 | $105M | 128k | 822.96 |
2023-06-30 | $90M | 125k | 718.54 |
2023-03-31 | $40M | 49k | 821.67 |
2022-12-31 | $37M | 51k | 721.49 |
2022-09-30 | $35M | 51k | 688.87 |
2022-06-30 | $36M | 60k | 591.13 |
2022-03-31 | $32M | 46k | 698.42 |
2021-12-31 | $36M | 56k | 631.54 |
2021-09-30 | $54M | 90k | 605.19 |
2021-06-30 | $55M | 98k | 558.54 |
2021-03-31 | $48M | 102k | 473.14 |
2020-12-31 | $66M | 138k | 483.11 |
2020-09-30 | $85M | 151k | 559.78 |
2020-06-30 | $97M | 156k | 623.64 |
2020-03-31 | $42M | 85k | 488.31 |
2019-12-31 | $16M | 43k | 375.49 |